| Schedule of Segment Reporting Information |
Segment results for the three-month period ended June 27, 2025 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 1,518.8 | | | $ | 675.7 | | | $ | 523.6 | | | $ | 319.5 | | | $ | — | | Cost of sales | (623.1) | | | (231.8) | | | (261.3) | | | (130.0) | | | — | | Gross profit | 895.7 | | | 443.9 | | | 262.3 | | | 189.5 | | | — | | Operating expenses (a) | (673.5) | | | (277.2) | | | (169.1) | | | (150.4) | | | (76.8) | | | | | | | | | | | | Operating profit (loss) | 222.2 | | | 166.7 | | | 93.2 | | | 39.1 | | | (76.8) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (32.1) | | | — | | | — | | | — | | | (32.1) | | | | | | | | | | | | Other non-operating expense, net | 1.9 | | | — | | | — | | | — | | | 1.9 | | Earnings before income taxes | $ | 192.0 | | | $ | 166.7 | | | $ | 93.2 | | | $ | 39.1 | | | $ | (107.0) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (137.8) | | | $ | (58.4) | | | $ | (28.7) | | | $ | (50.4) | | | $ | (0.3) | | | | | | | | | | | | Capital expenditure | $ | (36.7) | | | $ | (20.1) | | | $ | (11.6) | | | $ | (4.9) | | | $ | (0.1) | | | | | | | | | | | | (a) Unallocated Corporate Costs and Other included $41 million of Separation-related costs. Refer to Note 2 for further detail. |
Segment results for the three-month period ended June 28, 2024 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 1,552.4 | | | $ | 677.0 | | | $ | 551.8 | | | $ | 323.6 | | | $ | — | | Cost of sales | (624.1) | | | (221.7) | | | (266.3) | | | (136.1) | | | — | | Gross profit | 928.3 | | | 455.3 | | | 285.5 | | | 187.5 | | | — | | Operating expenses | (626.5) | | | (282.1) | | | (170.2) | | | (147.3) | | | (26.9) | | | | | | | | | | | | Operating profit (loss) | 301.8 | | | 173.2 | | | 115.3 | | | 40.2 | | | (26.9) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (38.7) | | | — | | | — | | | — | | | (38.7) | | Loss from divestiture (a) | (25.6) | | | — | | | — | | | — | | | (25.6) | | Other non-operating expense, net | (8.8) | | | — | | | — | | | — | | | (8.8) | | Earnings before income taxes | $ | 228.7 | | | $ | 173.2 | | | $ | 115.3 | | | $ | 40.2 | | | $ | (100.0) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (136.5) | | | $ | (57.1) | | | $ | (28.8) | | | $ | (50.4) | | | $ | (0.2) | | | | | | | | | | | | Capital expenditure | $ | (29.2) | | | $ | (14.9) | | | $ | (9.6) | | | $ | (3.1) | | | $ | (1.6) | | | | | | | | | | | | (a) Refer to Note 1 for further detail on Loss from divestiture. |
Segment results for the six-month period ended June 27, 2025 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 2,993.0 | | | $ | 1,347.1 | | | $ | 1,024.2 | | | $ | 621.7 | | | $ | — | | Cost of sales | (1,216.4) | | | (455.0) | | | (507.3) | | | (254.1) | | | — | | Gross profit | 1,776.6 | | | 892.1 | | | 516.9 | | | 367.6 | | | — | | Operating expenses (a) | (1,320.8) | | | (551.7) | | | (336.4) | | | (302.2) | | | (130.5) | | | | | | | | | | | | Operating profit (loss) | 455.8 | | | 340.4 | | | 180.5 | | | 65.4 | | | (130.5) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (64.1) | | | — | | | — | | | — | | | (64.1) | | | | | | | | | | | | Other non-operating expense, net | 1.7 | | | — | | | — | | | — | | | 1.7 | | Earnings before income taxes | $ | 393.4 | | | $ | 340.4 | | | $ | 180.5 | | | $ | 65.4 | | | $ | (192.9) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (272.7) | | | $ | (116.3) | | | $ | (55.9) | | | $ | (99.9) | | | $ | (0.6) | | | | | | | | | | | | Capital expenditure | $ | (63.4) | | | $ | (37.0) | | | $ | (17.2) | | | $ | (8.9) | | | $ | (0.3) | | | | | | | | | | | | (a) Unallocated Corporate Costs and Other included $64 million of Separation-related costs. Refer to Note 2 for further detail. |
Segment results for the six-month period ended June 28, 2024 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 3,076.9 | | | $ | 1,342.7 | | | $ | 1,110.8 | | | $ | 623.4 | | | $ | — | | Cost of sales | (1,244.4) | | | (444.1) | | | (539.0) | | | (261.3) | | | — | | Gross profit | 1,832.5 | | | 898.6 | | | 571.8 | | | 362.1 | | | — | | Operating expenses | (1,291.6) | | | (561.3) | | | (370.5) | | | (294.4) | | | (65.4) | | Gain on sale of property (a) | 63.1 | | | — | | | 63.1 | | | — | | | — | | Operating profit (loss) | 604.0 | | | 337.3 | | | 264.4 | | | 67.7 | | | (65.4) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (82.7) | | | — | | | — | | | — | | | (82.7) | | Loss from divestiture (a) | (25.6) | | | — | | | — | | | — | | | (25.6) | | Other non-operating expense, net | (33.0) | | | — | | | — | | | — | | | (33.0) | | Earnings before income taxes | $ | 462.7 | | | $ | 337.3 | | | $ | 264.4 | | | $ | 67.7 | | | $ | (206.7) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (273.3) | | | $ | (114.4) | | | $ | (58.2) | | | $ | (100.5) | | | $ | (0.2) | | | | | | | | | | | | Capital expenditure | $ | (55.6) | | | $ | (33.6) | | | $ | (13.7) | | | $ | (5.8) | | | $ | (2.5) | | | | | | | | | | | | (a) Refer to Note 1 for further detail on Gain on sale of property and Loss from divestiture. |
Segment Assets: | | | | | | | | | | | | | | | As of | | ($ in millions) | June 27, 2025 | | December 31, 2024 | | | | Intelligent Operating Solutions | $ | 6,343.2 | | | $ | 6,320.1 | | | | | Precision Technologies | 4,947.6 | | | 4,691.9 | | | | | Advanced Healthcare Solutions | 4,947.1 | | | 5,008.6 | | | | | Total segment assets | 16,237.9 | | | 16,020.6 | | | | Other (a) | 2,006.3 | | | 995.5 | | | | | | | | | | | Total assets | $ | 18,244.2 | | | $ | 17,016.1 | | | | | | | | | | (a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets. | | |
|